Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PHARMACOSMOS A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.0% 0.0% 2.3% 0.4% 0.7% 7.1% 7.1%   Credit score (0-100)   0 0 0 63 99 94 34 34   Credit rating   N/A N/A N/A BBB AAA AA BBB BBB   Credit limit (mDKK)   95.1 102.8 86.9 0.0 132.0 206.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   573 609 782 877 1,104 1,613 1,613 1,613   Gross profit   318 329 465 545 701 1,245 0.0 0.0   EBITDA   95.6 128 219 211 272 680 0.0 0.0   EBIT   95.6 128 219 211 272 680 0.0 0.0   Pre-tax profit (PTP)   102.6 59.6 -118.5 170.0 165.9 1,038.9 0.0 0.0   Net earnings   102.6 59.6 -118.5 170.0 114.3 789.7 0.0 0.0   Pre-tax profit without non-rec. items   95.6 128 219 211 161 798 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 4.4 6.7 0.0 0.0   Shareholders equity total   834 894 671 807 855 1,636 1,489 1,489   Interest-bearing liabilities   0.0 0.0 0.0 0.0 759 883 0.0 0.0   Balance sheet total (assets)   1,308 1,355 1,479 1,590 1,753 2,658 1,489 1,489   Net Debt   0.0 0.0 0.0 0.0 96.9 -168 -1,489 -1,489     See the entire balance sheet 1.0 Volume  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   573 609 782 877 1,104 1,613 1,613 1,613   Net sales growth   5.7% 6.3% 28.4% 12.1% 25.9% 46.1% 0.0% 0.0%   Gross profit   318 329 465 545 701 1,245 0.0 0.0   Gross profit growth   1.1% 3.4% 41.4% 17.3% 28.5% 77.7% -100.0% 0.0%   Employees   153 163 169 177 191 208 0 0   Employee growth %   0.0% 6.5% 3.7% 4.7% 7.9% 8.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,308 1,355 1,479 1,590 1,753 2,658 1,489 1,489   Balance sheet change%   12.6% 3.6% 9.1% 7.5% 10.3% 51.6% -44.0% 0.0%   Added value   95.6 128.3 219.3 210.9 272.2 679.5 0.0 0.0   Added value %   16.7% 21.1% 28.0% 24.1% 24.7% 42.1% 0.0% 0.0%   Investments   -588 0 0 0 105 -40 -65 0   Net sales trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   16.7% 21.1% 28.0% 24.1% 24.7% 42.1% 0.0% 0.0%   EBIT %   16.7% 21.1% 28.0% 24.1% 24.7% 42.1% 0.0% 0.0%   EBIT to gross profit (%)   30.1% 39.0% 47.2% 38.7% 38.8% 54.6% 0.0% 0.0%   Net Earnings %   17.9% 9.8% -15.2% 19.4% 10.3% 49.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   17.9% 9.8% -15.2% 19.4% 10.3% 49.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   16.7% 21.1% 28.0% 24.1% 14.6% 49.5% 0.0% 0.0%   ROA %   7.7% 9.6% 15.5% 13.7% 15.9% 34.8% 0.0% 0.0%   ROI %   8.1% 9.6% 15.5% 13.7% 16.6% 37.1% 0.0% 0.0%   ROE %   13.2% 6.9% -15.1% 23.0% 13.8% 63.4% 0.0% 0.0%   1.0 Solidity  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 100.0% 48.7% 61.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 80.8% 63.3% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 20.8% -1.8% -92.3% -92.3%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% 35.6% -24.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 88.9% 54.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 27.6% -3.6% 0.0% 0.0%   1.0 Liquidity  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 2.8 3.4 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 3.1 3.6 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 662.6 1,051.2 0.0 0.0   1.0 Capital use efficiency  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 37.6 53.5 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 139.6% 155.4% 92.3% 92.3%   Net working capital   0.0 0.0 0.0 0.0 805.5 864.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 72.9% 53.6% 0.0% 0.0%   1.0 Employee efficiency  2018 N/A 2019 N/A 2020 N/A 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   4 4 5 5 6 8 0 0   Added value / employee   1 1 1 1 1 3 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 1 1 1 1 3 0 0   EBIT / employee   1 1 1 1 1 3 0 0   Net earnings / employee   1 0 -1 1 1 4 0 0